OCRA Hosts Listening Session With FDA About COVID-19

In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.

Watch the full FDA listening session in the video below.

Posted on

Share this page